Midlands Academic Training Programme: IP and Commercialisation Workshop
Mon, 16 September 2019
10:00 – 16:30 BST
King Power Stadium
This workshop was designed for Midlands based Clinical Academics and other health related researchers to better understand the process of commercialisation for biomedical discoveries (therapies, devices and diagnostics). The workshop guided attendees through the identification and protection of intellectual property, regulatory considerations, how to effectively engage with commercial partners and where/how to apply for funding.
Session 1: Working successfully with industry
Professor Alison Goodall of University of Leicester and co-founder of Haemostatix Ltd
Alison is a founding Director of Haemostatix Ltd, a University of Leicester spin-out company developing novel therapeutic products to prevent bleeding. Research interests include unravelling genetic, clinical and therapeutic factors that affect haemostasis and thrombosis and understanding the role of platelets in promoting atherosclerosis.Professor Nicholas Barnes of University of Birmingham and co-founder of Celentyx Ltd
Nicholas is Professor of Neuropharmacology within the Institute of Clinical Sciences, and has been at the University of Birmingham Medical School since 1991. He is a World renowned translational pharmacologist and the Principal Founder of Celentyx Ltd, a venture capital funded pharmaceutical R&D company.
Session 2: Regulatory considerations: What you need to do to get your idea into a patient
Peter Rose, Managing Director, MAETRICS
Peter is the Managing Director and Practice Leader for Maetrics operations in Europe. Having worked in the medical device industry for over 20 years, he has a wealth of experience and knowledge in quality systems and regulatory affairs. He is a lead auditor, qualified microbiologist, and his roles include quality management, sterilization, cleanroom, quality systems and laboratory management. In addition to his Maetrics responsibilities, Peter is also a Director of Medilink East Midlands and a guest lecturer at the University of Nottingham, Nottingham Trent University, and the University of Sheffield.
Session 3: Intellectual Property: Case studies and horror stories
Catrin Petty, Senior Associate Patent Attorney, Venner Shipley
Catrin is a UK and European patent attorney in our Chemical and Life Sciences team. Catrin specialises in drafting, filing and prosecuting patent applications in a variety of fields, including agrochemistry, drug delivery, food technology, graphene, peptide chemistry, pharmaceuticals, polymers and medical devices. Catrin has worked with a large variety of clients including lone inventors, universities and SMEs, as well as large multinational pharmaceutical companies.
Session 4: It’s not the size of your IP but how you use it!
Carl Edwards, Leicester Precision Medicine Institute, University of Leicester
Carl Joined LPMI as Commercial Manager in January 2018 and is responsible for engaging with commercial partners and providing IP and commercialisation advice to LPMI members. Carl is an experienced commercial development manager who has provided consultancy services to pharmaceutical, medical devices companies and venture capital funds.
Session 5: How to engage with commercial partners to develop your product
Patrick Hall, Managing Director, Designing Science Ltd
Patrick has over 30 years’ experience in product development. For 8 years he was Development Director at Maddison, a med-tech product design company. He has worked in a broad range of industries including medical devices, life sciences, FMCG, business electronics and industrial products. He has a deep understanding of how products are transformed from ideas into reality and how to limit risks in a phased approach.
Session 6: How to and where to apply for funding: helpful hints and case studies
Session 7: Keynote: Spinning Out
Nick Duggan, founder and former CEO, Cellesce
Nick is an innovation and marketing professional with extensive experience across the medical technology, consumer products, financial services, and ICT sectors. He is a Partner at Viadynamics, a leading innovation and venturing agency, where he champions business model innovation for corporate clients, supports university clients in building capability for Knowledge Exchange and leads new venturing activities. Nick is also a founder and former CEO of Cellesce, a start-up company that aims to transform drug discovery and personalised medicine in the fight against cancer.
IAX Industry and Academia Exchange
The Medical Research Council (MRC) Proximity to Discovery scheme utilised creative approaches to reduce barriers between academia and industry engagement for all levels of University staff from postgraduate students, early career researchers, technical and academic staff to members of the research and enterprise division.
The overall IAX programme funded a variety of activities including a showcase partnering event, people exchanges, sand pit meetings, and industry training courses for academics.
The people exchanges (or secondments) enabled academics to experience work within an industry setting and conversely, industry members to spend time at the University to understand the research and development opportunities within an academic environment.